The evolving understanding of risk with calcitonin gene-related peptide monoclonal antibodies based on real-world data: A focus on hypertension and Raynaud phenomenon

Ilana D. Breen, Aaron R. Mangold, Juliana H. VanderPluym

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)1274-1276
Number of pages3
JournalHeadache
Volume61
Issue number8
DOIs
StatePublished - Sep 2021

Keywords

  • adverse effects
  • calcitonin gene-related peptide
  • hypertension
  • monoclonal antibody
  • Raynaud phenomenon
  • risk

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this